![]() Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. | ![]() Brii Biosciences Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. | ![]() Design Therapeutics Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates. | |
Founding Date | Founding Date 2004 | Founding Date 2018 | Founding Date 2017 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US | Locations CN HQ Beijing, CN Durham, US San Francisco, US San Mateo, US | Locations Carlsbad, US HQ |
Employees | Employees 158 | Employees 8510% decrease | Employees 54 |
Financial | |||
Net income | Net income (CHF61.7m) (FY, 2025) | Net income N/A | Net income ($69.8m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 415m | Total funding raised $ 45m |

Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses.
View company
Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates.
View company